FDA points assertion assessing plastic syringes made in China for potential machine defects – The Journal of Healthcare Contracting

FDA points assertion assessing plastic syringes made in China for potential machine defects – The Journal of Healthcare Contracting



December 1, 2023 – The U.S. Meals and Drug Administration (FDA) issued a security discover on November 30 informing customers, healthcare suppliers and healthcare amenities that the group is evaluating the potential for machine failure (comparable to leakage, breakage and injury). different issues) with plastic syringes manufactured in China.

The FDA is amassing and analyzing knowledge to judge Chinese language-made plastic syringes used to inject fluids into or withdraw fluids from the physique. Proper now the difficulty does not embrace glass syringes, prefilled syringes, or syringes used for oral or topical functions.

The FDA obtained details about high quality points related to a number of Chinese language syringe producers. We’re involved that sure syringes manufactured in China might not present constant and satisfactory high quality or efficiency.

Not all distributors are affected. In keeping with a BD press launch, the FDA security discover doesn’t apply to BD syringes as a result of they’re manufactured in america.

For extra info from the FDA, click on right here.

BD just isn’t affected by FDA spray notification

Leave a Reply

Your email address will not be published. Required fields are marked *